"
Team:SupBiotech-Paris/Acknowledgement
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) (→Students) |
Enguerrand (Talk | contribs) (→Students) |
||
| Line 70: | Line 70: | ||
:* Emmanuelle Chevrier from Sup’Biotech Paris | :* Emmanuelle Chevrier from Sup’Biotech Paris | ||
:* Noémi Combes from Sup’Biotech Paris | :* Noémi Combes from Sup’Biotech Paris | ||
| - | + | ||
:* Benoit Chevrier from IEJ Journalist School. | :* Benoit Chevrier from IEJ Journalist School. | ||
<html> | <html> | ||
Revision as of 14:46, 15 October 2009
Project
Introduction Current therapies Gene therapies DVS Concept Tissue Vector Cell Vector Therapeutic plasmid Conclusion Implementation Tissue targeting Antitumor action Treatment modeling Conclusion
Ressources
BioBricks Material & Method Bibliography
Ethics & Safety
Contents |
Scientists
UMR CNRS 8121 from Gustave Roussy Institute
- Dr. Lluis M. Mir
- Dr. Karim Benihoud
- Dr. Bassim Al-Sakere
- PhD worker Christian Bressy
- PhD worker Aude Silve
INSERM U872
- Dr. Srinivas Kaveri
AnyGenes
- Dr. Benyoussef Naimi
National Reference Center for Mycobacteria and the Resistance of Mycobacteria to Antituberculosis from CHU Pitié-Salpêtrière
- Dr. Nicolas Veziris
Imperial College
- Dr. Brian D Robertson
Our Sponsors
Students
- Emmanuelle Chevrier from Sup’Biotech Paris
- Noémi Combes from Sup’Biotech Paris
- Benoit Chevrier from IEJ Journalist School.
